Voltage-Gated Sodium Channel Blockers
"Voltage-Gated Sodium Channel Blockers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS.
| Descriptor ID |
D061567
|
| MeSH Number(s) |
D27.505.519.562.750.500 D27.505.954.411.720.500
|
| Concept/Terms |
Voltage-Gated Sodium Channel Blockers- Voltage-Gated Sodium Channel Blockers
- Voltage Gated Sodium Channel Blockers
- Voltage-Gated Sodium Channel Inhibitors
- Voltage Gated Sodium Channel Inhibitors
- Channel Blockers, Voltage-Gated Sodium
- Channel Blockers, Voltage Gated Sodium
- Voltage-Gated Sodium Channel Antagonists
- Voltage Gated Sodium Channel Antagonists
|
Below are MeSH descriptors whose meaning is more general than "Voltage-Gated Sodium Channel Blockers".
Below are MeSH descriptors whose meaning is more specific than "Voltage-Gated Sodium Channel Blockers".
This graph shows the total number of publications written about "Voltage-Gated Sodium Channel Blockers" by people in this website by year, and whether "Voltage-Gated Sodium Channel Blockers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 2 | 2 |
| 2018 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Voltage-Gated Sodium Channel Blockers" by people in Profiles.
-
Burashnikov A, Antzelevitch C. The Efficacy of I Na Block to Cardiovert Atrial Fibrillation Is Enhanced by Inhibition of I K1. J Cardiovasc Pharmacol. 2024 10 01; 84(4):434-439.
-
Burashnikov A, Barajas-Martinez H, Cox R, Demitrack MA, Fossler MJ, Kramer M, Kleiman RB, Kowey P, Antzelevitch C. Intracellular uptake of agents that block the hERG channel can confound the assessment of QT interval prolongation and arrhythmic risk. Heart Rhythm. 2021 12; 18(12):2177-2186.
-
Pazdera L, Sperling MR, Harvey JH, Sam MC, Strom LA, Blum D, Grinnell T, Cheng H. Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine. Epilepsia. 2018 03; 59(3):704-714.
-
Hasdemir C, Payzin S, Kocabas U, Sahin H, Yildirim N, Alp A, Aydin M, Pfeiffer R, Burashnikov E, Wu Y, Antzelevitch C. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia. Heart Rhythm. 2015 Jul; 12(7):1584-94.
-
Qi D, Yang Z, Robinson VM, Li J, Gao C, Guo D, Kowey PR, Yan GX. Heterogeneous distribution of INa-L determines interregional differences in rate adaptation of repolarization. Heart Rhythm. 2015 Jun; 12(6):1295-303.